Intravacc announces the publication of a GMP process for a semi-synthetic Shigella glycoconjugate vaccine candidate from Institut Pasteur
/PRNewswire/ -- Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, today announced the publication of...